Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revisionNext revision | Previous revisionBoth sides next revision |
pharmaceutical_companies:zymeworks [2022/04/28 17:19] liam | pharmaceutical_companies:zymeworks [2024/11/20 18:35] (current) liam [Affiliations] |
|---|
| {{ :pharmaceutical_companies:zymeworks_logo_color.jpeg?200|}} | {{ :pharmaceutical_companies:zymeworks_logo_color.jpeg?200|}} |
| |
| **Zymeworks** is a Canadian biotechnology company based in [[canada:british_columbia:Vancouver]], [[canada:British Columbia]]. | **Zymeworks** is a Canadian biotechnology company based in [[canada:british_columbia:Vancouver]], [[canada:British Columbia]]. The company develops [[:protein]] [[:therapeutics]] for the treatment of [[:cancer]] as well as for [[:autoimmune diseases|autoimmune]] and [[:inflammatory diseases]]. |
| | |
| | ===== Affiliations ===== |
| | |
| | In 2011, [[Merck]] entered an agreement with Zymeworks to use their Azymetric™ platform for the development and commercialization of bispecific antibodies against targets in multiple therapeutic fields.((//Merck & Co. Seals Bispecific Antibody Collaboration with Zymeworks.// (2011, August 29). GEN - Genetic Engineering and Biotechnology News. https://archive.ph/f4CA2)) The arrangement involved the joint development and improvement of the platform, as well as Merck taking the resulting novel antibody products through clinical development.((//FOI Request - HTH-2015-51828.// (2016, February 12). Government of British Columbia. https://web.archive.org/web/20220428045844/http://docs.openinfo.gov.bc.ca/Response_Package_HTH-2015-51828.pdf)) |
| | |
| | ===== External links ===== |
| | |
| | * [[https://wiki.whiteroseintelligence.com/en/Zymeworks|White Rose Wiki]] |